vTv Therapeutics Total Non Current Liabilities 2011-2026 | VTVT

Annual Total Non Current Liabilities vTv Therapeutics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	44.9 M	72.6 M	152 M	134 M	162 M	505 M	232 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
505 M	44.9 M	186 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
Autolus Therapeutics plc AUTL	50.6 M	$ 1.34	-3.6 %	$ 357 M	Britain
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
DBV Technologies S.A. DBVT	6.92 M	$ 20.13	-1.13 %	$ 2.81 B	France
Alterity Therapeutics Limited ATHE	73.6 K	$ 3.65	1.3 %	$ 8.78 B	Australia
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Dyadic International DYAI	8.14 M	$ 0.87	-	$ 31.5 M	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Aytu BioScience AYTU	42.1 M	$ 2.57	-3.57 %	$ 16.1 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Equillium EQ	8.33 M	$ 2.04	1.24 %	$ 117 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Fate Therapeutics FATE	29.7 M	$ 1.13	-5.04 %	$ 134 M	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Forte Biosciences FBRX	10.5 M	$ 26.57	0.49 %	$ 344 M	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Fennec Pharmaceuticals FENC	24.6 M	$ 6.14	-4.36 %	$ 175 M	USA
Foghorn Therapeutics FHTX	97.7 M	$ 4.74	-2.87 %	$ 299 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Amicus Therapeutics FOLD	245 M	$ 14.46	0.03 %	$ 4.46 B	USA
Aptose Biosciences APTO	27.9 M	-	-45.71 %	$ 1.2 M	Canada
Fulcrum Therapeutics FULC	5.54 M	$ 7.55	-3.58 %	$ 478 K	USA
Galectin Therapeutics GALT	52 K	$ 2.25	-12.3 %	$ 144 M	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
BioNTech SE BNTX	341 M	$ 87.65	-3.98 %	$ 27.2 B	Germany
Gilead Sciences GILD	29.2 B	$ 138.19	-1.38 %	$ 172 B	USA
Coherus BioSciences CHRS	189 M	$ 1.61	-3.59 %	$ 189 M	USA
Akari Therapeutics, Plc AKTX	50 K	$ 3.5	-1.13 %	$ 236 B	Britain
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Galmed Pharmaceuticals Ltd. GLMD	44 K	$ 0.54	4.26 %	$ 503 K	Israel
Genmab A/S GMAB	769 M	$ 27.01	-2.67 %	$ 17.2 B	Danmark
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	604 M	$ 314.44	-4.81 %	$ 41.2 B	USA
Gossamer Bio GOSS	37.2 M	$ 0.32	-7.11 %	$ 73.1 M	USA
Grifols, S.A. GRFS	7.22 B	$ 7.91	-3.95 %	$ 6.83 B	Spain
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
GT Biopharma GTBP	714 K	$ 0.42	-6.49 %	$ 2.32 M	USA
Aileron Therapeutics ALRN	4.59 M	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Halozyme Therapeutics HALO	388 M	$ 63.51	0.68 %	$ 7.61 B	USA